| Page No 1 2 3 4 |
| Phrase | Consultant | Town | Special Interests |
| acute oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, melanoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast malignancies, urological malignancies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, head and neck cancer, maxillofacial cancers, radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, urological cancer, renal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, chemotherapy, immunotherapy, metastatic cancer, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, sarcoma, paediatric radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, neuro-oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, genito-urinary cancers, skin cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck oncology, upper gastrointestinal malignancy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, tumours of the thorax and lower gastrointestinal tract |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lung cancer and mesothelioma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, neuro-oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, radiotherapy for melanoma, medical education |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, central nervous system tumours |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, genito-urinary oncology, radiotherapy for haematological malignancies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, cervical cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, bladder cancer, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology (bladder, prostate), renal and testicular cancers, low dose rate and high dose rate prostate radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, testicular cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancers, urological malignancies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, soft tissue and bone sarcomas, oropharyngeal cancer, laryngeal/hypopharyngeal cancer, head and neck sarcomas, salivary gland cancers, gastrointestinal stromal tumours (GIST), late radiotherapy toxicity, survivorship - resilience for patients |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, lymphoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck oncology, thyroid cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, brain tumours in children and adolescents |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, endocrine cancers, endometrial cancer, cervical cancer, ovarian cancer, thyroid, gynaecological sarcomas |
| Page No 1 2 3 4 |
